02039nam a22005057a 4500
210217s20212021 xxu||||| |||| 00| 0 eng d
2151-8378
01436319-202101000-00002 [pii]
10.1097/SPV.0000000000000978 [doi]
Ovid MEDLINE(R)
33369964
"First, Do No Harm"-Trainees' Observation of Risk Reduction in the Treatment of Overactive Bladder.
Female Pelvic Medicine & Reconstructive Surgery. 27(1):2-4, 2021 01 01.
Female pelvic med. reconstr. surg.. 27(1):2-4, 2021 01 01.
Female pelvic med. reconstr. surg.. 27(1):2-4, 2021 Jan 01.
Female pelvic medicine & reconstructive surgery
2021
FY2021
ppublish
2021-02-17
Female Pelvic Medicine & Reconstructive Surgery. 27(1):2-4, 2021 Jan 01.
FY2021
English
*Cholinergic Antagonists/ae [Adverse Effects]
*Dementia/ci [Chemically Induced]
*Urinary Bladder, Overactive/dt [Drug Therapy]
Acetanilides/tu [Therapeutic Use]
Aged
Dementia/ep [Epidemiology]
Dementia/pc [Prevention & Control]
Female
Humans
Insurance Coverage
Middle Aged
Risk
Thiazoles/tu [Therapeutic Use]
Urological Agents/tu [Therapeutic Use]
MedStar Washington Hospital Center
Obstetrics and Gynecology/Female Pelvic Medicine and Reconstructive Surgery
Journal Article
Ringel, Nancy E
Barnes H, Bennett AT, Brown OE, Cardenas-Trowers OO, Chang OH, Escobar C, Falk KN, Hall EF, Jeney SES, Mehta S, Menhaji K, Ringel NE, Sappenfield EC, Tellechea LM
https://dx.doi.org/10.1097/SPV.0000000000000978
https://dx.doi.org/10.1097/SPV.0000000000000978
ART
Article
0
0
0
0
Article
authcat
authcat
2021-02-17
0
33369964
33369964
2021-02-17
2021-02-17
ART
6129
6129